349 related articles for article (PubMed ID: 18637489)
21. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.
Zamò A; Cecconi D
J Proteomics; 2010 Jan; 73(3):508-20. PubMed ID: 19755177
[TBL] [Abstract][Full Text] [Related]
22. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
23. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
24. Towards defining biomarkers indicating resistances to targeted therapies.
Stehle F; Schulz K; Seliger B
Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers in cancer screening, research and detection: present and future: a review.
Kumar S; Mohan A; Guleria R
Biomarkers; 2006; 11(5):385-405. PubMed ID: 16966157
[TBL] [Abstract][Full Text] [Related]
26. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
27. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
28. Cancer proteomics: developments in technology, clinical use and commercialization.
Yeat NC; Lin C; Sager M; Lin J
Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
[TBL] [Abstract][Full Text] [Related]
29. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
30. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
Hudler P; Kocevar N; Komel R
ScientificWorldJournal; 2014; 2014():260348. PubMed ID: 24550697
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in oncoproteomics.
Jain KK
Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
34. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
35. Proteomics in cancer research: Are we ready for clinical practice?
Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
[TBL] [Abstract][Full Text] [Related]
36. Molecular biomarkers for cancer detection in blood and bodily fluids.
Feng Q; Yu M; Kiviat NB
Crit Rev Clin Lab Sci; 2006; 43(5-6):497-560. PubMed ID: 17050080
[TBL] [Abstract][Full Text] [Related]
37. Proteomic technology for biomarker profiling in cancer: an update.
Alaoui-Jamali MA; Xu YJ
J Zhejiang Univ Sci B; 2006 Jun; 7(6):411-20. PubMed ID: 16625706
[TBL] [Abstract][Full Text] [Related]
38. The cancer cell secretome: a good source for discovering biomarkers?
Pavlou MP; Diamandis EP
J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
[TBL] [Abstract][Full Text] [Related]
39. Secretome proteomics for discovery of cancer biomarkers.
Makridakis M; Vlahou A
J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
[TBL] [Abstract][Full Text] [Related]
40. Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
Mittal P; Klingler-Hoffmann M; Arentz G; Zhang C; Kaur G; Oehler MK; Hoffmann P
Proteomics Clin Appl; 2016 Mar; 10(3):217-29. PubMed ID: 26541900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]